Trough Concentration Over 12.1 mg/L is a Major Risk Factor of Vancomycin-Related Nephrotoxicity in Patients With Therapeutic Drug Monitoring-Reference-Cited by-同舟云学术

Trough Concentration Over 12.1 mg/L is a Major Risk Factor of Vancomycin-Related Nephrotoxicity in Patients With Therapeutic Drug Monitoring

Published:2014-10 Issue:5 Volume:36 Page:606-611
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Han Hye Kyung,An Hyungmi,Shin Kwang-Hee,Shin Donghoon,Lee Sue Hyun,Kim Ju Han,Cho Sang-Heon,Kang Hye-Ryun,Jang In-Jin,Yu Kyung-Sang,Lim Kyoung Soo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. . Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat.;Grundmann;Lancet,2006

2. The role of vancomycin in the treatment paradigm.;Stevens;Clin Infect Dis,2006

3. . Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.;Martin;Clin Biochem Rev,2010

4. . Is peak concentration needed in therapeutic drug monitoring of vancomycin A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant Staphylococcus aureus pneumonia.;Suzuki;Chemotherapy,2012

5. . Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.;Rybak;Clin Infect Dis,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is It Still Beneficial to Monitor the Trough Concentration of Vancomycin? A Quantitative Meta-Analysis of Nephrotoxicity and Efficacy;Antibiotics;2024-05-28

2. A Brief Review of Pharmacokinetic Assessments of Vancomycin in Special Groups of Patients with Altered Pharmacokinetic Parameters;Current Drug Safety;2023-11

3. Therapeutic Drug Monitoring of Vancomycin Concentrations for the Management of Bone and Joint Infections: An Urgent Need;Tropical Medicine and Infectious Disease;2023-02-13

4. Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters;Frontiers in Pharmacology;2022-08-24

5. Risk factors for vancomycin‐associated acute kidney injury: A systematic review and meta‐analysis;British Journal of Clinical Pharmacology;2022-06-15